SLDB
Solid Biosciences Present Svb Securities Global Biopharma
Wednesday, February 8, 2023 BiopharmaWatch Research 1 min read Key Takeaway: Solid Biosciences Present Svb Securities Global Biopharma
Price reaction · baseline $7.76 (2023-02-07 close) · hit after-hours · clean, no other SLDB news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma
Full Press Release Details
Solid Biosciences Present Svb Securities Global Biopharma.